Status:
UNKNOWN
COVID-19 Follow up Intensive Care Studies
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
Hanze University of Applied Sciences Groningen
Conditions:
Quality of Life
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Since the SARS-CoV-2 infection is relatively new, the long term attributable burden related to COVID19 has not been investigated yet. To date, in patients with COVID-19 and their family members, there...
Detailed Description
Study design The COVID-19 Follow up Intensive Care Study (COFICS) is a single center, prospective cohort study performed at a University Medical Center in The Netherlands. Study population The study ...
Eligibility Criteria
Inclusion
- ≥ 18 years old
- Ability to speak and write Dutch
- Ability to conduct a telephone call
- Diagnosed with COVID-19 infection (only in patients)
- 48 hours ICU admission (only in patients)
Exclusion
- Refuse to participate
- Serious language barrier
- Cognitive impairment
- Severe psychiatric disorder
- Chronic ventilator dependency (only in patients)
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04460170
Start Date
July 1 2020
End Date
February 1 2022
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands, 9700 RB